Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Optison imaging agent launched in U.S.

Jan. 29, 1998

Dopamine D4 receptor antagonists for imaging and therapy disclosed by Janssen

Jan. 29, 1998

New test for cardiovascular disease risk assessment from Myriad Genetics

Jan. 28, 1998

ProstaScint may predict response of prostate cancer patients to salvage radiotherapy

Jan. 26, 1998

Matritech receives SBIR grant for cancer test development

Jan. 26, 1998

LeuTech completes phase I

Jan. 20, 1998

Ground-breaking collaboration in MRI technology announced

Jan. 19, 1998

PD diagnostic technology available for licensing from NIH

Jan. 15, 1998

IND submitted for new atherosclerosis imaging agent from Diatide

Jan. 13, 1998

Diatide's acute thrombosis imaging agent scheduled for review by FDA panel

Jan. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.